What is Aurinia Pharmaceuticals's PEG ratio?

Aurinia Pharmaceuticals (AUPH) reported PEG ratio of 0× in Q1 2026.

What does PEG ratio mean?

The P/E ratio divided by the trailing-twelve-month net-income growth rate (in percentage points). Adjusts the earnings multiple for the pace of earnings growth.

Aurinia Pharmaceuticals AUPH PEG ratio

PEG ratio at other companies

Rogers CorporationROG

0.6×—

Ligand PharmaceuticalsLGND

9.6×+9.4×

AlkermesALKS

8.9×+8.6×

IncyteINCY

0×—

Bristol-Myers SquibbBMY

0.5×—

AbbottABT

0.1×-2.8×

Other financials

Income statement

See full

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

See full

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

See full

Operating cash flow$32.6M+2,405%

Valuation

See full

Market cap$2.39B+78.5%

Profitability

See full

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

See full

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Calculated from Aurinia Pharmaceuticals’s reported figures.

market cap/net income=0×

Based on the most recent quarter.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's peg ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aurinia Pharmaceuticals's PEG ratio?: Aurinia Pharmaceuticals (AUPH) reported PEG ratio of 0× in Q1 2026.
What does PEG ratio mean?: The P/E ratio divided by the trailing-twelve-month net-income growth rate (in percentage points). Adjusts the earnings multiple for the pace of earnings growth.